Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Dell and DOE Talk Partnering on Building AI Infrastructure
10:15

Mattel CEO Ynon Kreiz Talks Toy Industry, Supply Chain
08:24

US Olympic Silver Medalist Korey Dropkin Talks Curling, Rock League
09:02